PCD franchise & third-party manufacturing directory · listings since 2016
Tap a molecule to see other companies that offer it.
Offered bySonika Life Sciences Pvt Ltd
Glimepride 1mg + Metformin 500mg (SR) 1. Highly effective in patients having both high fasting and high post-prandial blood glucose levels. 2. The addition of glimepiride to MET is an effective treatment for patients inadequately controlled on sulfonylurea or Met alone.
Blister (Bi-Layered)
Glimepride 2mg + Metformin 500mg (SR) After the intensive teeatment, FPG,2 HPG & HBA1c decreased significantly(p>0.01); HOMA-IR desceased & HOMA-B incresed significantly (p<0.01) & TG,CHOL,LDL descreased significantly (p<0.01) after treatment
Blister (Bi-Layered)
Glimepride 1mg + Metformin 1000mg (SR) After the intensive teeatment, FPG,2 HPG & HBA1c decreased significantly(p>0.01); HOMA-IR desceased & HOMA-B incresed significantly (p<0.01) & TG,CHOL,LDL descreased significantly (p<0.01) after treatment
Blister (Bi-Layered)
Glimepride 2mg + Metformin 1000mg (SR) After the intensive teeatment, FPG,2 HPG & HBA1c decreased significantly(p>0.01); HOMA-IR desceased & HOMA-B incresed significantly (p<0.01) & TG,CHOL,LDL descreased significantly (p<0.01) after treatment
Blister (Bi-Layered)
Glimepride 1mg + Metformin 500mg (SR) + Pioglitazone 15 mg 1. Stimulates the release of insulin from functioning pancreatic beta cells. 2. Counters insulin resistance. 3. decreases heparic glucose production alo decreases intestinal absorption of glucose.
Blister (Bi-Layered)
Glimepride 2mg + Metformin 500mg (SR) + Pioglitazone 15 mg 1. Stimulates the release of insulin from functioning pancreatic beta cells. 2. Counters insulin resistance. 3. decreases heparic glucose production alo decreases intestinal absorption of glucose.
Blister (Bi-Layered)
Glimepride 1mg + Voglibose 0.2mg + Metformin 500mg (SR) 1. Voglibose scores over both acarbose and miglitol in terms of side effct profile. 2. proven efficacy. 3. metformin causes few adverse effects the most common is gastrointestinal upset and is associated with a low risk of hypoglycemia.
Blister (Bi-Layered)
Glimepride 2mg + Voglibose 0.2mg + Metformin 500mg (SR) 1. Voglibose scores over both acarbose and miglitol in terms of side effct profile. 2. proven efficacy. 3. metformin causes few adverse effects the most common is gastrointestinal upset and is associated with a low risk of hypoglycemia.
Blister (Bi-Layered)
Voglibose 0.2mg + Metformin Hydrochloride 500mg + Glimiperide 2mg
10*15 Blister
MH Mediday Healthcare
Product information is supplied by Sonika Life Sciences Pvt Ltd. Pharma Franchise Mart does not sell medicines. For medical use follow the prescribing information.
